Abstract
Rapid eye movement sleep behavior disorder (RBD) is an abnormal condition that constitutes dream enactment behavior occurring during rapid eye movement (REM) phase sleep with loss of normal muscular atonia. Idiopathic RBD is a recognized risk factor for the development of alpha-synuclein neuropathology, often referred to as Lewy body disorders (LBD) like Parkinson disease, multiple system atrophy and dementia with Lewy bodies, with conversion rates of 80–90 % over a lifetime. In the past decade, studies have described multiple features of idiopathic RBD subjects that resemble patients with alpha-synucleinopathies, with specific abnormalities in olfaction, vision, gait, cognition, autonomic dysfunction, impaired cortical activity, and dopaminergic abnormalities in neuroimaging, leading to the idea that idiopathic RBD is a prodromal synucleinopathy that can precede neurodegenerative disease by decades.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Darien I. American Academy of Sleep Medicine. International classification of sleep disorders.3rd ed: American Academy of Sleep Medicine 2014.
McCarter SJ, St Louis EK, Boswell CL, et al. Factors associated with injury in REM sleep behavior disorder. Sleep Med. 2014;15:1332–8.
Kang SH, Yoon IY, Lee SD, et al. REM sleep behavior disorder in the Korean elderly population: prevalence and clinical characteristics. Sleep. 2013;36:1147–52.
Boot BP, Boeve BF, Roberts RO, et al. Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study. Ann Neurol. 2012;71:49–56.
Postuma RB, Montplaisir JY, Pelletier A, et al. Environmental risk factors for REM sleep behavior disorder: a multicenter case-control study. Neurology. 2012;79:428–34.
Boeve BF. REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci. 2010;1184:15–54.
Hsieh KC, Nguyen D, Siegel JM, Lai YY. New pathways and data on rapid eye movement sleep behaviour disorder in a rat model. Sleep Med. 2013;14:719–28.
Schenck CH, Boeve BF, Mahowald MW. Delayed emergence of a parkinsonian disorder or dementia in 81 % of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med. 2013;14:744–8.
Gagnon JF, Bedard MA, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology. 2002;59:585–9.
Plazzi G, Corsini R, Provini F, et al. REM sleep behavior disorders in multiple system atrophy. Neurology. 1997;48:1094–7.
Braak H, Ghebremedhin E, Rub U, et al. Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res. 2004;318:121–34.
Iranzo A, Molinuevo JL, Santamaria J, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol. 2006;5:572–7.
Postuma RB, Gagnon JF, Vendette M, et al. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology. 2009;72:1296–300.
Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183–94.
Aarsland D, Bronnick K, Larsen JP, et al. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology. 2009;72:1121–6.
Iranzo A, Tolosa E, Gelpi E, et al. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol. 2013;12:443–53. Definitive study that showed Lewy body disease present either clinically or with post-morten pathology in 97% of RBD cases.
Postuma RB, Iranzo A, Hogl B, et al. Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol. 2015;77:830–9. This is a multicenter study with the largest cohort population, and the first to identify risk factors for neurodegeneration in RBD.
McDade EM, Boot BP, Christianson TJ, et al. Subtle gait changes in patients with REM sleep behavior disorder. Mov Disord : Off J Mov Disord Soc. 2013;28:1847–53.
Chen TZ, Xu GJ, Zhou GA, et al. Postural sway in idiopathic rapid eye movement sleep behavior disorder: a potential marker of prodromal Parkinson’s disease. Brain Res. 2014;1559:26–32.
Terzaghi M, Zucchella C, Rustioni V, et al. Cognitive performances and mild cognitive impairment in idiopathic rapid eye movement sleep behavior disorder: results of a longitudinal follow-up study. Sleep. 2013;36:1527–32.
Howell MJ, Schenck CH. Rapid eye movement sleep behavior disorder and neurodegenerative disease. JAMA Neurol. 2015;72:707–12. A peer review of the last decade of publications on RBD and neurodegenerative disease.
Frauscher B, Nomura T, Duerr S, et al. Investigation of autonomic function in idiopathic REM sleep behavior disorder. J Neurol. 2012;259:1056–61.
Postuma RB, Gagnon JF, Vendette M, et al. REM sleep behaviour disorder in Parkinson’s disease is associated with specific motor features. J Neurol Neurosurg Psychiatry. 2008;79:1117–21.
Postuma RB, Gagnon JF, Montplaisir J. Rapid eye movement sleep behavior disorder as a biomarker for neurodegeneration: the past 10 years. Sleep Med. 2013;14:763–7. A summary of the multiple biomarkers for neurodegeneration in RBD.
Boeve BF, Dickson DW, Olson EJ, et al. Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. Sleep Med. 2007;8:60–4.
Uchiyama M, Isse K, Tanaka K, et al. Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology. 1995;45:709–12.
Postuma RB, Gagnon JF, Vendette M, et al. Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol. 2011;69:811–8.
Postuma RB, Gagnon JF, Bertrand JA, et al. Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials. Neurology. 2015;84:1104–13.
McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology. 2005;65:1863–72.
Molano J, Boeve B, Ferman T, et al. Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. Brain : J Neurol. 2010;133:540–56.
Mahlknecht P, Iranzo A, Hogl B, et al. Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD. Neurology. 2015;84:654–8.
Mahlknecht P, Seppi K, Frauscher B, et al. Probable RBD and association with neurodegenerative disease markers: a population-based study. Mov Disord : Off J Mov Disord Soc. 2015;30:1417–21.
Dugger BN, Boeve BF, Murray ME, et al. Rapid eye movement sleep behavior disorder and subtypes in autopsy-confirmed dementia with Lewy bodies. Mov Disord : Off J Mov Disord Soc. 2012;27:72–8.
Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670–6.
Iranzo A, Santamaria J, Rye DB, et al. Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Neurology. 2005;65:247–52.
Berg D, Postuma RB, Adler CH, et al. MDS research criteria for prodromal Parkinson’s disease. Mov Disord : Off J Mov Disord Soc. 2015;30:1600–11.
Anang JB, Gagnon JF, Bertrand JA, et al. Predictors of dementia in Parkinson disease: a prospective cohort study. Neurology. 2014;83:1253–60.
Postuma RB, Gagnon JF, Rompre S, Montplaisir JY. Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease. Neurology. 2010;74:239–44.
Schenck CH, Boeve BF. The strong presence of REM sleep behavior disorder in PD: clinical and research implications. Neurology. 2011;77:1030–2.
Gagnon JF, Vendette M, Postuma RB, et al. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson’s disease. Ann Neurol. 2009;66:39–47.
Onofrj M, Thomas A, D’Andreamatteo G, et al. Incidence of RBD and hallucination in patients affected by Parkinson’s disease: 8-year follow-up. Neurol Sci : Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2002;23 Suppl 2:S91–4.
Cochen De Cock V. Recent data on rapid eye movement sleep behavior disorder in patients with Parkinson disease: analysis of behaviors, movements, and periodic limb movements. Sleep Med. 2013;14:749–53.
Unger MM, Belke M, Menzler K, et al. Diffusion tensor imaging in idiopathic REM sleep behavior disorder reveals microstructural changes in the brainstem, substantia nigra, olfactory region, and other brain regions. Sleep. 2010;33:767–73.
Scherfler C, Frauscher B, Schocke M, et al. White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study. Ann Neurol. 2011;69:400–7.
Ellmore TM, Hood AJ, Castriotta RJ, et al. Reduced volume of the putamen in REM sleep behavior disorder patients. Parkinsonism Relat Disord. 2010;16:645–9.
Salsone M, Cerasa A, Arabia G, et al. Reduced thalamic volume in Parkinson disease with REM sleep behavior disorder: volumetric study. Parkinsonism Relat Disord. 2014;20:1004–8.
Zhang JL, Liu G, Hang W, et al. Olfactory function in patients with idiopathic rapid eye movement sleep behavior disorder. Zhonghua er bi yan hou tou jing wai ke za zhi = Chin J Otorhinolaryngol Head Neck Surg. 2013;48:394–7.
St Louis EK, McCarter SJ, Boeve BF, et al. Lesional REM sleep behavior disorder localizes to the dorsomedial pons. Neurology. 2014;83:1871–3.
Tribl GG, Bor-Seng-Shu E, Trindade MC, et al. Wilson’s disease presenting as rapid eye movement sleep behavior disorder: a possible window to early treatment. Arq Neuropsiquiatr. 2014;72:653–8.
Compta Y, Valente T, Saura J, et al. Correlates of cerebrospinal fluid levels of oligomeric- and total-alpha-synuclein in premotor, motor and dementia stages of Parkinson’s disease. J Neurol. 2015;262:294–306.
Murray ME, Ferman TJ, Boeve BF, et al. MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies. Neurology. 2013;81:1681–9.
Garcia-Lorenzo D, Longo-Dos Santos C, Ewenczyk C, et al. The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson’s disease. Brain : J Neurol. 2013;136:2120–9.
Ellmore TM, Castriotta RJ, Hendley KL, et al. Altered nigrostriatal and nigrocortical functional connectivity in rapid eye movement sleep behavior disorder. Sleep. 2013;36:1885–92. This study demonstrated changes in neural conectivity in RBD patients similar to other synucleinopathies.
Ellmore T, Castriotta R, Suescun J, Schiess M. Negative functional connectivity between substantia nigra and hippocampus in REM sleep behavior disorder. Sleep Med. 2015;16:S12–3.
Mayer G, Bitterlich M, Kuwert T, et al. Ictal SPECT in patients with rapid eye movement sleep behaviour disorder. Brain : J Neurol. 2015;138:1263–70.
Aurora RN, Zak RS, Maganti RK, et al. Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med : JCSM : Off Publ Am Acad Sleep Med. 2010;6:85–95.
McCarter SJ, Boswell CL, St Louis EK, et al. Treatment outcomes in REM sleep behavior disorder. Sleep Med. 2013;14:237–42.
Kashihara K, Nomura T, Maeda T, et al. Beneficial effects of Ramelteon on rapid eye movement sleep behavior disorder associated with Parkinson’s disease—results of a multicenter open trial. Intern Med. 2016;55:231–6. Tokyo, Japan.
Devnani P, Fernandes R. Management of REM sleep behavior disorder: an evidence based review. Ann Indian Acad Neurol. 2015;18:1–5.
Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38 % of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology. 1996;46:388–93.
Schenck CHBS, Mahowald MW. S REM behavior disorder (RBD): delayed emergence of parkinsonism and/or dementia in 65 % of older men initially diagnosed with idiopathic RBD, and an analysis of the minimum-maximum tonic and/or phasic electromyographic abnormalities found during REM sleep. Sleep. 2003;26:A316.
Iranzo AMJ, Santamaria J, Serradell M, Marti M, Valldeoriola F, Vilaseca I, et al. Sixty four percent of patients with idiopathic rem sleep behavior disorder developed a neurological disorder after a mean clinical follow-up of 7 years. Sleep. 2008;31:A280.
Wing YK, Li SX, Mok V, et al. Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2012;83:470–2.
Iranzo A, Fernandez-Arcos A, Tolosa E, et al. Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients. PLoS ONE. 2014;9, e89741.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Neurology of Aging
Rights and permissions
About this article
Cite this article
Suescun, J., Ellmore, T.M. & Schiess, M. REM Sleep Behavior Disorder: a Prodromal Synucleinopathy. Curr Geri Rep 5, 95–102 (2016). https://doi.org/10.1007/s13670-016-0174-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13670-016-0174-9